» Articles » PMID: 37344757

Unraveling Pathophysiologic Mechanisms Contributing to Symptoms in Patients with Post-acute Sequelae of COVID-19 (PASC): A Retrospective Study

Overview
Journal Physiol Rep
Specialty Physiology
Date 2023 Jun 21
PMID 37344757
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with post-acute sequelae of COVID-19 (PASC) present with a decrease in physical fitness. The aim of this paper is to reveal the relations between the remaining symptoms, blood volume distribution, exercise tolerance, static and dynamic lung volumes, and overall functioning. Patients with PASC were retrospectively studied. Pulmonary function tests (PFT), 6-minute walk test (6MWT), and cardiopulmonary exercise test were performed. Chest CT was taken and quantified. Patients were divided into two groups: minor functional limitations (MFL) and severe functional limitations (SFL) based on the completed Post-COVID-19 Functional Status scale (PCFS). Twenty one patients (3 M; 18 FM), mean age 44 (IQR 21) were studied. Eighteen completed the PCFS (8 MFL; 10 SFL). VO max was suboptimal in both groups (not significant). 6MWT was significantly higher in MFL-group (p = 0.043). Subjects with SFL, had significant lower TLC (p = 0.029). The MFL-group had more air trapping (p = 0.036). Throughout the sample, air trapping correlated significantly with residual volume (RV) in L (p < 0.001). An increase in air trapping was related to an increase in BV5 (p < 0.001). Mean BV5 was 65% (IQR 5%). BV5% in patients with PASC was higher than in patients with acute COVID-19 infection. This increase in BV5% in patients with PASC is thought to be driven by the air trapping in the lobes. This study reveals that symptoms are more driven by occlusion of the small airways. Patients with more physical complaints have significantly lower TLC. All subjects encounter physical limitations as indicated by suboptimal VO max. Treatment should focus on opening or re-opening of small airways by recruiting alveoli.

Citing Articles

Personalized pulmonary rehabilitation program for patients with post-acute sequelae of COVID-19: A proof-of-concept retrospective study.

Dierckx W, De Backer W, De Meyer Y, Lauwers E, Franck E, De Backer J Physiol Rep. 2024; 12(3):e15931.

PMID: 38296347 PMC: 10830387. DOI: 10.14814/phy2.15931.


Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post-acute sequelae of COVID-19 (PASC): A retrospective study.

Dierckx W, De Backer W, Ides K, De Meyer Y, Lauwers E, Franck E Physiol Rep. 2023; 11(12):e15754.

PMID: 37344757 PMC: 10284821. DOI: 10.14814/phy2.15754.

References
1.
Jia X, Han X, Cao Y, Fan Y, Yuan M, Li Y . Quantitative inspiratory-expiratory chest CT findings in COVID-19 survivors at the 6-month follow-up. Sci Rep. 2022; 12(1):7402. PMC: 9070972. DOI: 10.1038/s41598-022-11237-1. View

2.
Lins M, Vandevenne J, Thillai M, Lavon B, Lanclus M, Bonte S . Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT. Acad Radiol. 2020; 27(10):1449-1455. PMC: 7381940. DOI: 10.1016/j.acra.2020.07.019. View

3.
Dierckx W, De Backer W, Ides K, De Meyer Y, Lauwers E, Franck E . Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post-acute sequelae of COVID-19 (PASC): A retrospective study. Physiol Rep. 2023; 11(12):e15754. PMC: 10284821. DOI: 10.14814/phy2.15754. View

4.
Miller Jr W, Chatzkel J, Hewitt M . Expiratory air trapping on thoracic computed tomography. A diagnostic subclassification. Ann Am Thorac Soc. 2014; 11(6):874-81. DOI: 10.1513/AnnalsATS.201311-390OC. View

5.
Morris M, Pershad Y, Kang P, Ridenour L, Lavon B, Lanclus M . Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease. Eur Respir J. 2021; 58(3). PMC: 7908189. DOI: 10.1183/13993003.04133-2020. View